Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Robert Price Honored as Fellow of ASTRO
PHILADELPHIA (July 18, 2018) – Robert Price, PhD, DABR, chief clinical physicist within the Department of Radiation Oncology at Fox Chase Cancer Center, will be honored as a fellow of the American Society for Radiation Oncology (ASTRO) at the organization’s 60th annual meeting on October 23, 2018 in San Antonio, Texas.
The ASTRO Fellows Program honors radiation oncologists and medical physicists who have made significant contributions to the field, and who have been active members of ASTRO for at least 15 years and given the equivalent of 10 years of service to the organization. The FASTRO program began in 2006, and Price joins a group of less than 20 medical physicists nationwide who have earned this designation.
Over his 20-year career at Fox Chase Price has been active in the clinic, as a researcher, and as a teacher. His clinical work includes leading quality assurance in radiotherapy to deliver high-quality treatments. This includes calibration of linear accelerators, brachytherapy sources, and imaging devices, as well as the implementation of all ancillary equipment and the training of technical personnel on each new technique. Price’s broad research includes work on intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), and most recently, image assessment to evaluate treatment response. He also teaches radiotherapy physics to residents in radiation oncology and medical physics.
Price’s previous honors include the Leadership Forum Excellence Recognition Award from Fox Chase and a fellowship from the American Association of Physicists in Medicine (FAAPM).
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427